Phathom Pharmaceuticals (PHAT) Cash from Investing Activities Growth (1y) (2020 - 2026)

Phathom Pharmaceuticals (PHAT) Cash from Investing Activities Growth (1y) (2020 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Investing Growth (1y) (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	90.55%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	91.53%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	25.90%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	7,936.68%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	26.37%
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-157.08%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-89.24%
10	Phathom Pharmaceuticals	767.07 Mn	581.73 Mn	59.18 Mn	54.64%

Download Data